AKT1 and cancer: We have recently identified a synthetic derivative of the natural compound InsP5, named 2-O-Bn-InsP5, which potently and specifically inhibits PDK1 in vitro as well as the PDK1-dependent phosphorylation of AKT Thr308 in cancer cell lines and in vivo21.